Psychopharmacologic Approaches to Treatment of Psychopathology

Psychopharmacologic Approaches to Treatment of Psychopathology

Discussion: Foundational Neuroscience

As a psychiatric mental health nurse practitioner, it is essential for you to have a strong background in foundational neuroscience. In order to diagnose and treat clients, you must not only understand the pathophysiology of psychiatric disorders, but also how medications for these disorders impact the central nervous system. These concepts of foundational neuroscience can be challenging to understand. Therefore, this Discussion is designed to encourage you to think through these concepts, develop a rationale for your thinking, and deepen your understanding by interacting with your colleagues.

1. Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents.
2. Compare and contrast the actions of g couple proteins and ion gated channels.
3. Explain the role of epigenetics in pharmacologic action.
4. Explain how this information may impact the way you prescribe medications to clients. Include a specific example of a situation or case with a client in which the psychiatric mental health nurse practitioner must be aware of the medication’s action.

Name: NURS_6630_Week1_Discussion_Rubric

  Outstanding Performance Excellent Performance Competent Performance Proficient Performance Room for Improvement
Main Posting:
Response to the discussion question is reflective with critical analysis and synthesis representative of knowledge gained from the course readings for the module and current credible sources.
44 (44%) – 44 (44%)

 

Thoroughly responds to the discussion question(s)

is reflective with critical analysis and synthesis representative of knowledge gained from the course readings for the module and current credible sources.

supported by at least 3 current, credible sources

40 (40%) – 43 (43%)

 

Responds to the discussion question(s)

is reflective with critical analysis and synthesis representative of knowledge gained from the course readings for the module.

75% of post has exceptional depth and breadth

supported by at least 3 credible references Psychopharmacologic Approaches to Treatment of Psychopathology

35 (35%) – 39 (39%)

 

Responds to most of the discussion question(s)

is somewhat reflective with critical analysis and synthesis representative of knowledge gained from the course readings for the module.

50% of post has exceptional depth and breadth

supported by at least 3 credible references

31 (31%) – 34 (34%)

 

Responds to some of the discussion question(s)

one to two criteria are not addressed or are superficially addressed

is somewhat lacking reflection and critical analysis and synthesis

somewhat represents knowledge gained from the course readings for the module.

post is cited with fewer than 2 credible references

0 (0%) – 30 (30%)

 

Does not respond to the discussion question(s)

lacks depth or superficially addresses criteria

lacks reflection and critical analysis and synthesis

does not represent knowledge gained from the course readings for the module.

contains only 1 or no credible references

Main Posting:
Writing
6 (6%) – 6 (6%)

 

Written clearly and concisely

Contains no grammatical or spelling errors

Fully adheres to current APA manual writing rules and style

5.5 (5.5%) – 5.5 (5.5%)

 

Written clearly and concisely

May contain one or no grammatical or spelling error

Adheres to current APA manual writing rules and style

5 (5%) – 5 (5%)

 

Written concisely

May contain one to two grammatical or spelling error

Adheres to current APA manual writing rules and style

4.5 (4.5%) – 4.5 (4.5%)

 

Written somewhat concisely

May contain more than two spelling or grammatical errors

Contains some APA formatting errors

0 (0%) – 4 (4%)

 

Not written clearly or concisely

Contains more than two spelling or grammatical errors

Does not adhere to current APA manual writing rules and style

Main Posting:
Timely and full participation
10 (10%) – 10 (10%)

 

Meets requirements for timely and full participation

posts main discussion by due date

0 (0%) – 0 (0%)

 

NA

0 (0%) – 0 (0%)

 

NA

0 (0%) – 0 (0%)

 

NA

0 (0%) – 0 (0%)

 

Does not meet requirement for full participation

First Response:

 

 

Post to colleague’s main post that is reflective and justified with credible sources.

9 (9%) – 9 (9%)

 

Response exhibits critical thinking and application to practice settings

responds to questions posed by faculty

the use of scholarly sources to support ideas demonstrates synthesis and understanding of learning objectives

8.5 (8.5%) – 8.5 (8.5%)

 

Response exhibits critical thinking and application to practice settings

Psychopharmacologic Approaches to Treatment of Psychopathology

7.5 (7.5%) – 8 (8%)

 

Response has some depth and may exhibit critical thinking or application to practice setting

6.5 (6.5%) – 7 (7%)

 

Response is on topic, may have some depth

0 (0%) – 6 (6%)

 

Response may not be on topic, lacks depth

First Response:
Writing
6 (6%) – 6 (6%)

 

Communication is professional and respectful to colleagues

Response to faculty questions are fully answered if posed

Provides clear, concise opinions and ideas that are supported by two or more credible sources

Response is effectively written in Standard Edited English

5.5 (5.5%) – 5.5 (5.5%)

 

Communication is professional and respectful to colleagues

Response to faculty questions are answered if posed

Provides clear, concise opinions and ideas that are supported by two or more credible sources

Response is effectively written in Standard Edited English

5 (5%) – 5 (5%)

 

Communication is mostly professional and respectful to colleagues

Response to faculty questions are mostly answered if posed

Provides opinions and ideas that are supported by few credible sources

Response is written in Standard Edited English

4.5 (4.5%) – 4.5 (4.5%)

 

Responses posted in the discussion may lack effective professional communication

Response to faculty questions are somewhat answered if posed

Few or no credible sources are cited

0 (0%) – 4 (4%)

 

Responses posted in the discussion lack effective

Response to faculty questions are missing

No credible sources are cited

First Response:
Timely and full participation
5 (5%) – 5 (5%)

 

Meets requirements for timely and full participation

posts by due date

0 (0%) – 0 (0%)

 

NA

0 (0%) – 0 (0%)

 

NA

0 (0%) – 0 (0%)

 

NA

0 (0%) – 0 (0%)

 

Does not meet requirement for full participation

Second Response:
Post to colleague’s main post that is reflective and justified with credible sources.
9 (9%) – 9 (9%)

 

Response exhibits critical thinking and application to practice settings * responds to questions posed by faculty

the use of scholarly sources to support ideas demonstrates synthesis and understanding of learning objectives

8.5 (8.5%) – 8.5 (8.5%)

 

Response exhibits critical thinking and application to practice settings

Psychopharmacologic Approaches to Treatment of Psychopathology

7.5 (7.5%) – 8 (8%)

 

Response has some depth and may exhibit critical thinking or application to practice setting

6.5 (6.5%) – 7 (7%)

 

Response is on topic, may have some depth

0 (0%) – 6 (6%)

 

Response may not be on topic, lacks depth

Second Response:
Writing
6 (6%) – 6 (6%)

 

Communication is professional and respectful to colleagues

Response to faculty questions are fully answered if posed

Provides clear, concise opinions and ideas that are supported by two or more credible sources

Response is effectively written in Standard Edited English

5.5 (5.5%) – 5.5 (5.5%)

 

Communication is professional and respectful to colleagues

Response to faculty questions are answered if posed

Provides clear, concise opinions and ideas that are supported by two or more credible sources

Response is effectively written in Standard Edited English NURS_6630

5 (5%) – 5 (5%)

 

Communication is mostly professional and respectful to colleagues

Response to faculty questions are mostly answered if posed

Provides opinions and ideas that are supported by few credible sources

Response is written in Standard Edited English

4.5 (4.5%) – 4.5 (4.5%)

 

Responses posted in the discussion may lack effective professional communication

Response to faculty questions are somewhat answered if posed

Few or no credible sources are cited

0 (0%) – 4 (4%)

 

Responses posted in the discussion lack effective

Response to faculty questions are missing

No credible sources are cited

Second Response:
Timely and full participation
5 (5%) – 5 (5%)

 

Meets requirements for timely and full participation

Posts by due date

0 (0%) – 0 (0%)

 

NA

     
 
MORE INFO 

Psychopharmacologic Approaches to Treatment of Psychopathology

Introduction

ABSTRACT: In the last decade, a number of research have demonstrated that psychotropic drugs have potential to affect the activity of serotonin transporter (SERT) and/or reuptake of serotonin in the brain. Also, recent studies suggest that blockade of SERT may be involved in some psychiatric disorders. In this review, we summarize the evidence showing that antidepressants (e.g., SSRIs and tricyclics), antipsychotics, and mood stabilizers can increase the binding affinity of these psychotropics at SERT. The consequences affect all types of antidepressants, but there is considerable overlap among them; tricyclics seem to be better than SSRIs at blocking serotonergic action on 5-HT1A receptors.

General Principles in the Use of Psychoactive Medications

The use of psychoactive medications is an important aspect of patient care, but it needs to be done carefully and with a plan. The most important principle in this regard is that the patient should be educated about his or her treatment options and monitored closely for side effects. Dosage titration can be accomplished using either a fixed dosing schedule (such as 1 mg per day) or flexible dosing (such as every 2 hours). Patients should also be told how they will receive their medication, whether through pills, liquid doses in a glass of water, or through an injection into their arm. Finally, patients should be encouraged not to increase dosage beyond what has been prescribed unless their doctor recommends it; if you do so anyway because you think you are feeling better because your symptoms have gone away—or worse yet: if someone tells us that our medication was too strong for them!—we may consider adjusting our next dose down by half instead of stopping completely until we’ve had time for another evaluation cycle before making any changes again.”

The Use of Psychopharmacologic Agents in Depression and Anxiety Disorders

There are several medications used to treat depression, anxiety disorders, bipolar disorder and psychotic disorders.

  • Antidepressants: Selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). SSRIs may cause weight gain in some patients; TCAs often produce a more severe withdrawal syndromes than MAOIs and can be potentially fatal if taken with certain drugs such as St. John’s Wort or phenelzine sulfate.

  • Benzodiazepines: Short-acting benzodiazepines such as alprazolam or lorazepam are useful for short-term use at low doses to help control anxiety while waiting for the antidepressant effects of another treatment to kick in

The Use of Psychopharmacologic Agents in Bipolar Disorder

The use of psychopharmacologic agents in bipolar disorder has been reviewed. It is important to note that antidepressants are not effective in treating mania or bipolar depression. Antipsychotics are also ineffective in the treatment of mania, but can be used as an adjunct to lithium for prophylaxis and augmentation of mood stabilizers.

Antidepressants have limited use for the treatment of bipolar depression because they may cause hypomania or mania if taken at higher dosages than recommended by the manufacturer (e.g., 10-20 mg/day). Lithium remains the only medication approved by the FDA specifically for use in managing symptoms associated with bipolar disorder; however, its use must be carefully monitored due to its potential side effects such as weight gain and diarrhea

Psychotic Disorders

Antipsychotics are used to treat psychotic disorders, including schizophrenia. Antipsychotics can be used as a first-line treatment or as an adjunct to other treatments, such as antidepressants. They may also be used in the maintenance treatment of psychotic disorders.

Antipsychotic medications include:

Takeaway:

Psychopharmacologic agents are the cornerstone of treatment for many psychiatric disorders. In some cases, they can be used to treat both acute and chronic symptoms; in others, they are used alone or in combination with psychotherapy.

The most commonly prescribed medications include antidepressants (such as selective serotonin reuptake inhibitors), antipsychotics (such as haloperidol) and mood stabilizers such as lithium. These medications may be effective at reducing anxiety symptoms if they are taken before or just after an episode begins but do not prevent recurrence once it has started.[1]

Conclusion

Psychiatry treatment for psychiatric illness has changed with the times and new treatments are continually being researched and tested.

As mentioned previously, there is no one medication that has been proven to cure all psychiatric disorders but there are medications used in combination with psychotherapy which can be extremely useful. Some of these newer medications include, clomipramine (clomipramine hydrochloride, clomiPRAMINE HCl), fluoxetine (eosinopenicillamine, Prozac) and paroxetine (Paxil). These drugs are known as selective serotonin-reuptake inhibitors (SSRI’s) and although they don’t directly affect people’s mood or emotions they do have an effect on neurotransmitters such as serotonin, norepinephrine and dopamine.

The SSRI’s come in a variety of forms including capsules, tablets and liquid preparations. The most commonly prescribed is sertraline (Zoloft) however there are also: citalopram (Cipra), escitalopram oxalate (Lexapro), fluoxetine hydrochloride (Prozac) paroxetine hydrochloride(Paxil), fluvoxamine maleate(Luvox) venlafaxine succinate(Effexor). As well as this newer generation of antidepressants there is also bupropion oxtibum(Wellbutrin ), mirtazapine(Remeron ) or reboxetine(Wellbutrin SR). These drugs work by increasing levels of monoamines in the brain which reduces anxiety by blocking the reuptake mechanism involved in anxiety symptoms while still maintaining normal levels of mood stabilizing neurotransmitters such as serotonin.

There are many other new recent products out on the market like St John’s wort which


Leave a Reply

Your email address will not be published. Required fields are marked *